Ari Chaouat
Overview
Explore the profile of Ari Chaouat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
3419
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boucly A, Montani D, Bauer F, Artaud-Macari E, Bergot E, Boissin C, et al.
Eur Respir J
. 2025 Jan;
PMID: 39884763
Background: European guidelines recommend initial monotherapy in PAH patients with cardiovascular (CV) comorbidities based on the limited of evidence for combination therapy in this growing population. Methods: A retrospective analysis...
2.
3.
Farkouh C, Chaouat A, Guillaumot A, Baptista B, Chabot F, Valentin S
Respir Med Res
. 2025 Jan;
87():101153.
PMID: 39765128
Background: Pulmonary hypertension (PH) is common during chronic obstructive pulmonary disease (COPD), particularly in patients with severe COPD. These patients can be classified into different PH groups due to frequent...
4.
Valentin S, Baptista B, Chaouat A, Chabot F
Rev Prat
. 2024 May;
74(4):427-429.
PMID: 38814040
COPD EXACERBATIONS. COPD exacerbations, characterized by an acute worsening of dyspnea and/or cough and sputum volume beyond daily variations, are a public health issue because of their frequency, the number...
5.
Boucly A, Beurnier A, Turquier S, Jevnikar M, de Groote P, Chaouat A, et al.
Eur Respir J
. 2024 Apr;
64(3).
PMID: 38663975
Background: Haemodynamic variables are prognostic factors in pulmonary arterial hypertension (PAH). However, right heart catheterisation (RHC) is not systematically recommended to assess the risk status during follow-up. This study aimed...
6.
Valentin S, Regnault V, Gueant J, Baptista B, Abel T, Lacolley P, et al.
Allergy
. 2024 Apr;
79(8):2270-2273.
PMID: 38610102
No abstract available.
7.
Grynblat J, Bogaard H, Eyries M, Meyrignac O, Savale L, Jais X, et al.
Eur Respir J
. 2024 Mar;
63(4).
PMID: 38514094
Background: Bone morphogenetic proteins 9 and 10 (BMP9 and BMP10), encoded by and , respectively, play a pivotal role in pulmonary vascular regulation. variants have been reported in pulmonary arterial...
8.
Baptista B, Valentin S, Chaouat A, Chabot F
Rev Prat
. 2024 Feb;
74(2):194-198.
PMID: 38415426
EVOLUTION OF CONCEPTS. Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory disease responsible for significant morbidity and mortality. The natural history of this disease is complex. The first...
9.
Pequignot B, Chaouat A, Chabot F, Levy B, Valentin S
Front Med (Lausanne)
. 2024 Feb;
11:1283065.
PMID: 38379558
Pulmonary arterial hypertension (PAH) is characterized by a progressive increase in pulmonary vascular resistance (PVR) due to vascular remodeling of the small pulmonary arteries. In advanced RV failure or severe...
10.
Boucly A, Solinas S, Beurnier A, Jais X, Keddache S, Eyries M, et al.
ERJ Open Res
. 2024 Jan;
10(1).
PMID: 38226059
Introduction: Pulmonary veno-occlusive disease (PVOD) is a rare and severe subtype of pulmonary arterial hypertension (PAH). Although European Society of Cardiology/European Respiratory Society (ESC/ERS) guidelines advise assessing PAH severity at...